At a glance
ClinicalIndex Comparison RecordN/ACompleted· 18 enrolled
Drug / intervention
Uncovered CGM during radiologic proceduresother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Accuracy of Dexcom G6 After Radiation Exposure-A Cross Sectional and Longitudinal Analysis
In Brief
A clinical study evaluating Uncovered CGM during radiologic procedures for Diabetes. Completed, enrolled 18 participants across 1 site.
Detailed Summary
A single-center prospective trial on the effects of standard of care radiation exposure on the Dexcom G6 continuous glucose monitoring (CGM) device.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes
CountriesUnited States
CollaboratorsDexCom, Inc.
Timeline
N/ACompletedFinished
2023202420252026
Enrollment StartMar 2022
First PostedNov 2022
Primary CompletionOct 2023
Study CompletionMay 2024
TodayJul 2026
First PostedNov 7, 2022
Enrollment StartMar 1, 2022
Primary CompletionOct 20, 2023
Study CompletionMay 1, 2024
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 3.7 years ago
Interventions
Uncovered CGM during radiologic proceduresother
Dexcom G6 CGM will not be covered during radiologic procedures.